Form 4 Tracker
SUPERNUS PHARMACEUTICALS, INC.
SUPN

34 insider filings · Latest: Mar 16, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 19, 2026Feb 19 9:22 PMBETHANY SENSENIG
Proposed Sale
4,475$50.20$224.6K

View →

Dec 19, 2025Dec 19 9:23 PMFRANK MOTTOLA
Proposed Sale
20,000$49.28$985.6K

View →

Oct 9, 2025Oct 9 8:20 PMJACK A. KHATTAR
Proposed Sale
59,900$48.00$2.9M

View →

Oct 9, 2025Oct 9 8:19 PMCHARLES NEWHALL
Proposed Sale
25,000$48.00$1.2M

View →

Oct 2, 2025Oct 2 8:23 PMJACK A. KHATTAR
Proposed Sale
1,904$48.04$91.5K

View →

Oct 1, 2025Oct 1 8:28 PMJACK A. KHATTAR
Proposed Sale
40,173$47.79$1.9M

View →

Sep 30, 2025Sep 30 8:34 PMJACK A. KHATTAR
Proposed Sale
8,588$47.60$408.8K

View →

Sep 29, 2025Sep 29 8:37 PMJACK A. KHATTAR
Proposed Sale
10,235$47.03$481.4K

View →

Sep 23, 2025Sep 23 8:21 PMJACK A. KHATTAR
Proposed Sale
29,513$46.98$1.4M

View →

Sep 22, 2025Sep 22 8:26 PMJACK A KHATTAR
Proposed Sale
16,587$46.04$763.7K

View →

Sep 12, 2025Sep 12 8:05 PMFRANK MOTTOLA
Proposed Sale
5,000$45.87$229.3K

View →

Sep 8, 2025Sep 8 8:28 PMJACK A KHATTAR
Proposed Sale
6,322$46.00$290.8K

View →

Sep 5, 2025Sep 5 8:25 PMJACK A KHATTAR
Proposed Sale
55,578$45.43$2.5M

View →

Aug 28, 2025Aug 28 8:23 PMJACK A KHATTAR
Proposed Sale
24,150$45.07$1.1M

View →

Aug 27, 2025Aug 27 8:28 PMJACK A KHATTAR
Proposed Sale
10,650$44.32$472.0K

View →

Aug 25, 2025Aug 25 8:38 PMJACK A KHATTAR
Proposed Sale
1,000$44.88$44.9K

View →

Aug 25, 2025Aug 25 8:37 PMCHARLES NEWHALL
Proposed Sale
4,588$44.88$205.9K

View →

Aug 25, 2025Aug 25 8:09 PMFRANK MOTTOLA
Proposed Sale
14,000$44.51$623.1K

View →

Aug 22, 2025Aug 22 9:04 PMCHARLES NEWHALL
Proposed Sale
1,412$43.32$61.2K

View →

Aug 22, 2025Aug 22 8:47 PMJACK A KHATTAR
Proposed Sale
1,500$43.32$65.0K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 24, 2026Feb 25 9:54 PMFrank MottolaSVP, Chief Tech. Ops. Officer
Disposition
3,1252,500(D)

View →

Feb 24, 2026Feb 25 9:51 PMJonathan RubinSVP, Chief Medical Officer
Disposition
3,1252,500(D)

View →

Feb 24, 2026Feb 25 9:36 PMGeorges GemayelDirector
Disposition
4,4750(D)

View →

Feb 23, 2026Feb 25 9:36 PMGeorges GemayelDirector
Option Exercise
15,000$12.980(D)

View →

Feb 19, 2026Feb 23 9:39 PMBethany SensenigDirector
Option Exercise
4,4750(D)

View →

Feb 18, 2026Feb 20 9:49 PMTimothy C DecSenior Vice-President & CFO
Grant/Award
20,500$50.203,000(D)

View →

Feb 18, 2026Feb 20 9:48 PMPadmanabh P. BhattSr. VP of IP, CSO
Grant/Award
16,500$50.203,000(D)

View →

Feb 18, 2026Feb 20 9:47 PMJonathan RubinSVP, Chief Medical Officer
Grant/Award
16,500$50.203,000(D)

View →

Feb 18, 2026Feb 20 9:46 PMFrank MottolaSVP, Chief Tech. Ops. Officer
Grant/Award
16,500$50.203,000(D)

View →

Feb 18, 2026Feb 20 9:46 PMJack A. KhattarDirector, President, CEO
Grant/Award
341,610$50.20341,610(D)

View →

Feb 18, 2026Feb 20 9:45 PMGeorges GemayelDirector
Grant/Award
7,966$50.204,977(D)

View →

Feb 18, 2026Feb 20 9:44 PMCarrolee BarlowDirector
Grant/Award
7,966$50.204,977(D)

View →

Feb 18, 2026Feb 20 9:43 PMBethany SensenigDirector
Grant/Award
7,966$50.204,977(D)

View →

Feb 18, 2026Feb 20 9:40 PMCharles W Newhall IIIDirector
Grant/Award
7,966$50.204,977(D)

View →

Feb 18, 2026Feb 20 9:39 PMFrederick M. HudsonDirector
Grant/Award
7,966$50.204,977(D)

View →

← Previous

Page 2 of 2